ESOPMay 8, 2026, 04:04 PM
BridgeBio Grants 115,007 RSUs to 52 New Employees
AI Summary
BridgeBio Pharma's compensation committee approved equity grants of 115,007 restricted stock units (RSUs) to 52 new employees. These grants are intended as an inducement for their employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over time, with one-fourth vesting on May 16, 2027, and the remainder vesting quarterly thereafter, contingent on continued employment.
Key Highlights
- BridgeBio's compensation committee approved equity grants for 52 new employees.
- A total of 115,007 shares in restricted stock units (RSUs) were granted.
- One-fourth of the RSUs will vest on May 16, 2027.
- The remaining shares will vest on a quarterly basis thereafter.
- Grants are an inducement for employees entering employment with the Company.
- Awards were granted under a plan adopted in November 2019.
Price Impact
More from BBIO